-
Important news
-
News
-
Shenzhen
-
China
-
World
-
Opinion
-
Sports
-
Kaleidoscope
-
Photos
-
Business
-
Markets
-
Business/Markets
-
World Economy
-
Speak Shenzhen
-
Health
-
Leisure
-
Culture
-
Travel
-
Entertainment
-
Digital Paper
-
In-Depth
-
Weekend
-
Newsmaker
-
Lifestyle
-
Diversions
-
Movies
-
Hotels and Food
-
Special Report
-
Yes Teens!
-
News Picks
-
Tech and Science
-
Glamour
-
Campus
-
Budding Writers
-
Fun
-
Qianhai
-
Advertorial
-
CHTF Special
-
Futian Today
在线翻译:
szdaily -> Speak Shenzhen -> 
Class-action lawsuit 集体诉讼
    2021-04-20  08:53    Shenzhen Daily

周五,广州市中级人民法院在其官网发布了特别代表人诉讼权利登记公告,正式将康美药业的普通诉讼转为特别代表人诉讼,这是国内首起集体诉讼案。 请看本报昨日的报道:

China launched the country’s first class-action lawsuit against a listed firm Friday, targeting Kangmei Pharmaceutical Co., as regulators vowed “zero tolerance” against accounting fraud and other capital markets “tumors.”

The China Securities Investor Service Center, a government-affiliated body, is suing Kangmei on behalf of more than 50 individual investors in a landmark case in China’s capital markets, the China Securities Regulatory Commission (CSRC) said.

报道中的class-action lawsuit就是“集体诉讼”。

A class-action lawsuit is a legal action filed against a defendant by a group of individuals. It is designed for situations in which many individuals have suffered similar injuries as a result of the defendant’s actions.

集体诉讼指一群人对一个共同被告发起的诉讼。适用于多人由于该被告的行为承受相似的损失的情形。

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010-2020, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@126.com